Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor-Reference-Cited by-同舟云学术

Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor

Published:2024-04 Issue: Volume:968 Page:176381
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Liu Zhiyi,Hua Wei,Jin Sinan,Wang Yueying,Pang Yuxin,Wang Benshuai,Zhao Nan,Song Yuejia,Qi Jiping

Funder

National Natural Science Foundation of China National Outstanding Youth Science Fund Project

Publisher

Elsevier BV

Reference47 articles.

1. Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes;Abdelsaid;Diabetologia,2017

2. Silymarin ameliorates diabetes-induced Proangiogenic response in brain endothelial cells through a GSK-3β inhibition-induced reduction of VEGF Release;Alhusban;J. Diabetes Res.,2017

3. Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK;Angé;Sci. Rep.,2021

4. Canagliflozin prevents scopolamine-induced memory impairment in rats: comparison with galantamine hydrobromide action;Arafa;Chem. Biol. Interact.,2017

5. Canagliflozin inhibits human endothelial cell proliferation and tube formation;Behnammanesh;Front. Pharmacol.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment;GeroScience;2024-06-03